Publications & Posters

BRD4 Profiling Identifies Critical Chronic Lymphocytic Leukemia Oncogenic Circuits and Reveals Sensitivity to PLX51107, a Novel Structurally Distinct BET Inhibitor

https://doi.org/10.1158/2159-8290.CD-17-0902

b2 Adrenergic-Neurotrophin Feedforward Loop Promotes Pancreatic Cancer

https://doi.org/10.1016/j.ccell.2017.11.007

Resistance to BET inhibitors involves the Wnt/β-catenin Pathway in Uveal Melanoma

Download PDF

Nerve growth factor promotes gastric tumorigenesis through aberrant cholinergic signaling

https://doi.org/10.1016/j.ccell.2016.11.005

Response and Resistance to Bromodomain Inhibition in Acute Myeloid Leukemia

Download PDF

Broad Anti-Tumor Activity of a Novel BET Bromodomain Inhibitor

Download PDF

A novel inhibitor of BET family bromodomains demonstrates in vivo and in vitro potency in B-cell malignancy

Download PDF

Efficacy and Mechanismof Action of the Novel Bromodomain Inhibitor, PLX51107, in B Cell Malignancies

Download PDF

Cross Talk between Neuroregulatory Molecule and Monocyte: Nerve Growth Factor Activates the Inflammasome

https://doi.org/10.1371/journal.pone.0121626